Hypothyroidism affects approximately 0.5% of women of reproductive age
All medications come from licensed 503A compounding pharmacies, serve all 50 states without insurance requirements, and are HSA/FSA eligibleensuring accessibility alongside clinical efficacy
Measurements were validated using the Wave software (Agilent, Santa Clara, California, USA) and normalized to DNA concentrations per well, analyzed in stained cells (Hoechst 33342) using a plate reader (Tecan Infinite M200, Tecan Group Ltd., Mnnedorf, Switzerland) with an excitation wavelength of 350 nm and an emission wavelength of 461 nm
In the Retatrutide Phase 2 obesity trial, the weight-loss curve had not clearly flattened by week 48
Compounded formulations are not FDA-approved as drugs but are legally manufactured under 503A pharmacy regulations